Dr. Ying Amanda Wang is a research fellow in the Renal and Metabolic Division in The George Institute. She is also a consultant nephrologist and general physician. After completion of her PhD at the University of Sydney, she continues clinical research at the George Institute, supported by a John Chalmer’s Post-doctoral Research Fellowship. Amanda is interested in acute kidney injury, chronic kidney disease, dialysis therapy, and musculoskeletal health in patients with kidney disease.

Professor Rodgers has a track record in cardiovascular disease prevention, innovation and public-private partnerships, with an interest in scale-able interventions to address major risks to health. He is currently Acting Director of the Cardiovascular Division at The George Institute, Australia and Chair of Clinical Epidemiology, Faculty of Medicine, Imperial College of London.

After graduating in medicine in the United Kingdom he trained in epidemiology and public health in New Zealand. He was the Principal Author of the 2002 World Health Report, the main annual publication for WHO. Professor Rodgers has led developments of an affordable four-in-one cardiovascular combination pill ('polypill'). He led a clinical trial program in economically developed and developing countries, funded by the Wellcome Trust, European Union and others.  

Professor Rodgers also developed a world first cell phone based smoking cessation programme for youth, which disseminated proven health support messages in an age-appropriate, affordable medium.  Over 6,000 patients were involved in clinical trials that demonstrated a 50% increase in quit rates. The service has been rolled out by Departments of Health in NZ, UK and India, with over 2 million users to date. A follow-on program delivering cognitive behavioural therapy for depression prevention was successfully trialled among 1,200 at-risk teenagers.

Professor Anushka Patel is CEO and Director of The George Institute for Global Health and Scientia Professor at UNSW, Sydney.  She is a cardiologist with research interests in the prevention and management of common chronic conditions through large-scale clinical trials and implementation science. 

Anushka undertook her medical training at the University of Queensland, with subsequent postgraduate research degrees from Harvard University and University of Sydney. Anushka is a Fellow of the Royal Australasian College of Physicians and of the Australian Academy of Health and Medical Sciences and is a Director and Trustee of the Pulmonary Vascular Research Institute.

Bala Venkatesh is Director of Intensive care at the Wesley Hospital, Pre-Eminent specialist in Intensive Care Medicine at the Princess Alexandra Hospital, Brisbane, Professor of Intensive Care Medicine at the University of Queensland, and. at the University of New South Wales, and Professorial Fellow at the George Institute for Global Health, Sydney Australia. He is the Chairman of the Queensland Health Statewide Sepsis Steering Committee. He is a Fellow of the Australian Academy of Health and Medical Sciences

He has completed Fellowship training in Internal Medicine, Anaesthesia and Intensive Care Medicine.  He then undertook a research degree from the University of Birminghan, UK which led to the award of an MD.  He pioneered the development of a continuous blood gas monitoring system which reached clinical application.

He served as the President for the College of Intensive Care Medicine of Australia and New Zealand between 2014-2016.  He led the international taskforce on gender equity in Intensive Care which influenced guidelines in the World federation of Intensive Care. As President of the College of Intensive Care, he led the task force on bullying and discrimination which have informed College policy.

He led the NHMRC funded multi-center international ADRENAL trial which is largest septic shock trial to date. This was published in the New England Journal of Medicine and ranked in the top 12 articles of 2018. He has served on several  Data Safety Monitoring Committees and on the Management committee of RCTs in sepsis. His research interests include glucocorticoid physiology in critical illness including the development of the idea of the "sick euadrenal state, sepsis and vitamin D in critical illness.

In 2020, following the Covid-19 pandemic, he contributed to the REMAP-CAP steroid trial design and development and was on its writing committee recently reported in JAMA, which influenced guideline development. He was instrumental in the development of the George Institute’s Covid-19 research program in India and played a  key role in the set up of the COVID Steroid 2 trial in India which was also published in JAMA. He is currently investigating the role of fludrocortisone in septic shock.

He has published more than 250 papers, 40 book chapters, and edited 2 books. He has supervised 8 PhD students. He is now a Level 3 NHMRC Investigator Fellow.

Bijini is Data Manager at the George Institute for Global Health. She has completed Masters in Computer Applications from Kakatiya University, Warangal, India. She has more than 9 years of experience with expertise in developing databases for surveys, community and hospital based observational studies and randomised clinical trials using different electronic data capture platforms. Her work at George includes database setup and deployment, database maintenance including mid-study updates, data reviews, data cleaning, database lock and archival.